WO2024182624 - TOPICAL PAIN RELIEF COMPOSITION

National phase entry is expected:
Publication Number WO/2024/182624
Publication Date 06.09.2024
International Application No. PCT/US2024/017899
International Filing Date 29.02.2024
Title **
[English] TOPICAL PAIN RELIEF COMPOSITION
[French] COMPOSITION TOPIQUE POUR SOULAGER LA DOULEUR
Applicants **
ACHELON, INC. 1640 Steinhart Avenue Redondo Beach, California 90278, US
Inventors
DAWKINS, Manju Chacko 1640 Steinhart Avenue Redondo Beach, California 90278, US
Priority Data
63/487,751   01.03.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing2939
EPO Filing, Examination41970
Japan Filing535
South Korea Filing576
USA Filing, Examination17005
MasterCard Visa

Total: 63025

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to topical formulations, creams, serums, kits and adhesive patches including arnica, black pepper, and turmeric. Also provided are methods for decreasing soreness, pain, bruising, and/or swelling in a subject by administering topical formulations and adhesive patches.[French] La présente invention concerne des formulations topiques, des crèmes, des sérums, des kits et des timbres adhésifs comprenant de l'arnica, du poivre noir et du curcuma. L'invention concerne également des procédés pour réduire l'endolorissement, la douleur, les ecchymoses et/ou la tuméfaction chez un sujet par l'administration de formulations topiques et de timbres adhésifs.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙